Panbela Therapeutics Inc (PBLA)

$0.32 +0.00 (0.63%)
Market Cap 1.56M
Revenue (ttm) 0.00
Net Income (ttm) -25.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.23
Volume 300
Avg Vol 18,642
Day's Range N/A - N/A
Shares Out 4.86M
Stochastic %K 59%
Beta 1.33
Analysts Strong Sell
Price Target $25.00

Latest News on PBLA

No data available.